These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 4309742

  • 1. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator. 4. Antifibrinolytic action of sex hormones, especially a conjugated estrogen (Premarin) and its application.
    Mori N, Takemoto J.
    Acta Obstet Gynaecol Jpn; 1969 Jul; 16(3):137-42. PubMed ID: 4309742
    [No Abstract] [Full Text] [Related]

  • 2. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
    Miyatani K, Fukui I.
    Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
    [No Abstract] [Full Text] [Related]

  • 3. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN, Kizim AI.
    Vopr Med Khim; 1984 Mar; 30(5):13-22. PubMed ID: 6084892
    [Abstract] [Full Text] [Related]

  • 4. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H.
    Thromb Diath Haemorrh; 1973 May 10; 29(2):253-75. PubMed ID: 4271586
    [No Abstract] [Full Text] [Related]

  • 5. Effect of antifibrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery.
    Ambrus JL, Schimert G, Lajos TZ, Ambrus CM, Mink IB, Lassman HB, Moore RH, Melzer J.
    J Med; 1971 May 10; 2(2):65-81. PubMed ID: 4329735
    [No Abstract] [Full Text] [Related]

  • 6. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
    Frick G, Frick U.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966 May 10; 86(4):389-403. PubMed ID: 4168276
    [No Abstract] [Full Text] [Related]

  • 7. Studies on the participation of Hageman factor in fibrinolysis.
    McDonagh RP, Ferguson JH.
    Thromb Diath Haemorrh; 1970 Oct 31; 24(1):1-9. PubMed ID: 4249468
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator].
    Takemoto J.
    Kumamoto Igakkai Zasshi; 1969 Apr 25; 43(4):332-59. PubMed ID: 5820070
    [No Abstract] [Full Text] [Related]

  • 11. [Antiplasmin and its effect on the process of fibrinolysis in experiments].
    Kudriashov BA, Pastorova VE.
    Biull Eksp Biol Med; 1966 Feb 25; 61(2):40-2. PubMed ID: 4235805
    [No Abstract] [Full Text] [Related]

  • 12. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
    Klöcking HP, Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969 Feb 25; 92(1):84-9. PubMed ID: 4189378
    [No Abstract] [Full Text] [Related]

  • 13. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"].
    Daver J, Albugues MJ, du Pasquier JP, Ricoeur M.
    Pathol Biol (Paris); 1970 Feb 25; 18(11):687-94. PubMed ID: 4247466
    [No Abstract] [Full Text] [Related]

  • 14. [Inhibitor of fibrinolysis from pancreas pantrypin].
    Lakin KM, Efimov VS, Polonskaia LB.
    Farmakol Toksikol; 1969 Feb 25; 32(6):712-5. PubMed ID: 5381603
    [No Abstract] [Full Text] [Related]

  • 15. [Study of the fibrinogen splitting products in the blood plasma in hyperfibrinolysis].
    Veremienko KN, Varetskaia TV, Kizim AI, Gerasimenko NG.
    Ukr Biokhim Zh; 1976 Feb 25; 48(3):337-42. PubMed ID: 134480
    [Abstract] [Full Text] [Related]

  • 16. [Antifibrinolytic agents, a new class of drugs].
    Markwardt F.
    Internist (Berl); 1966 Aug 25; 7(8):400-5. PubMed ID: 4863412
    [No Abstract] [Full Text] [Related]

  • 17. In vivo studies on the mechanism of the antifibrinolytic action of E-aminocaproic acid (EACA).
    Lukasiewicz H, Niewiarowski S.
    Thromb Diath Haemorrh; 1968 Jul 31; 19(3):584-92. PubMed ID: 4236825
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(3):391-404. PubMed ID: 5314899
    [No Abstract] [Full Text] [Related]

  • 19. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE.
    Angiologica; 1968 Jun 30; 5(2):66-79. PubMed ID: 4232516
    [No Abstract] [Full Text] [Related]

  • 20. The effects of some synthetic compounds on in vitro fibrinolytic activity measured by different methods and the relevance to activity in vivo.
    Baillie AJ, Sim AK.
    Thromb Diath Haemorrh; 1972 Dec 31; 28(3):351-8. PubMed ID: 4265316
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.